Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 581

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Associations between blood type and COVID-19 infection, intubation, and death

Open access
Zietz, Michael, Zucker, Jason, Tatonetti, Nicholas P.·2020·Nature Communications

Published version of a preprint

Abstract

The rapid global spread of the novel coronavirus SARS-CoV-2 has strained healthcare and testing resources, making the identification and prioritization of individuals most at-risk a critical challenge. Recent evidence suggests blood type may affect risk of severe COVID-19. Here, we use observational healthcare data on 14,112 individuals tested for SARS-CoV-2 with known blood type in the New York Presbyterian (NYP) hospital system to assess the association between ABO and Rh blood types and infection, intubation, and death. We find slightly increased infection prevalence among non-O types. Risk of intubation was decreased among A and increased among AB and B types, compared with type O, while risk of death was increased for type AB and decreased for types A and B. We estimate Rh-negative blood type to have a protective effect for all three outcomes. Our results add to the growing body of evidence suggesting blood type may play a role in COVID-19.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-020-19623-x

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 57

  1. Zheng, Z. et al. Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J. Infect. 81, e16–e25 (2020). · DOI · Paper page
  2. Zhao, J. et al. Relationship between the ABO blood group and the COVID-19 susceptibility. medRxiv. https://doi.org/10.1101/2020.03.11.20031096 (2020). · DOI
  3. Ellinghaus, D. et al. Genomewide association study of severe Covid-19 with respiratory failure. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2020283 (2020). · DOI · Paper page
  4. Chung, C.-M. et al. A genome-wide association study identifies new loci for ACE activity: potential implications for response to ACE inhibitor. Pharmacogenomics J. 10, 537–544 (2010). · DOI
  5. Kamatani, Y. et al. Genome-wide association study of hematological and biochemical traits in a Japanese population. Nat. Genet. 42, 210–215 (2010). · DOI · Paper page
  6. van Rooij, F. J. A. et al. Genome-wide trans-ethnic meta-analysis identifies seven genetic loci influencing erythrocyte traits and a role for RBPMS in erythropoiesis. Am. J. Hum. Genet. 100, 51–63 (2017). · DOI
  7. Smith, N. L. et al. Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor. Circulation 121, 1382–1392 (2010). · DOI · Paper page
  8. Williams, F. M. K. et al. Ischemic stroke is associated with the ABO locus: The EuroCLOT study. Ann. Neurol. 73, 16–31 (2013). · DOI
  9. van Loon, J. et al. Genome-wide association studies identify genetic loci for low von Willebrand factor levels. Eur. J. Hum. Genet. 24, 1035–1040 (2015). · DOI
  10. Sabater-Lleal, M. et al. Genome-wide association transethnic meta-analyses identifies novel associations regulating coagulation factor VIII and von Willebrand factor plasma levels. Circulation 139, 620–635 (2019). · DOI · Paper page
  11. Reilly, M. P. et al. Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies. Lancet 377, 383–392 (2011). · DOI · Paper page
  12. Schunkert, H. et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat. Genet. 43, 333–338 (2011). · DOI · Paper page
  13. Dichgans, M. et al. Shared genetic susceptibility to ischemic stroke and coronary artery disease. Stroke 45, 24–36 (2014). · DOI · Paper page
  14. Nelson, C. P. et al. Association analyses based on false discovery rate implicate new loci for coronary artery disease. Nat. Genet. 49, 1385–1391 (2017). · DOI · Paper page
  15. van der Harst, P. & Verweij, N. Identification of 64 novel genetic loci provides an expanded view on the genetic architecture of coronary artery disease. Circ. Res. 122, 433–443 (2018). · DOI · Paper page
  16. Malik, R. et al. Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nat. Genet. 50, 524–537 (2018). · DOI · Paper page
  17. Scott, R. A. et al. An expanded genome-wide association study of type 2 diabetes in Europeans. Diabetes 66, 2888–2902 (2017). · DOI · Paper page
  18. Xue, A. et al. Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes. Nat. Commun. 9, 2941 (2018). · DOI · Paper page
  19. Trégouët, D.-A. et al. Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. Blood 113, 5298–5303 (2009). · DOI · Paper page
  20. Germain, M. et al. Genetics of venous thrombosis: insights from a new genome wide association study. PLoS ONE 6, e25581 (2011). · DOI
  21. Heit, J. A. et al. A genome-wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q. J. Thrombosis Haemost. 10, 1521–1531 (2012). · DOI
  22. Tang, W. et al. A genome-wide association study for venous thromboembolism: the extended Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium. Genet. Epidemiol. 37, 512–521 (2013). · DOI
  23. Germain, M. et al. Meta-analysis of 65,734 individuals identifies TSPAN15 and SLC44A2 as two susceptibility loci for venous thromboembolism. Am. J. Hum. Genet. 96, 532–542 (2015). · DOI · Paper page
  24. Klarin, D., Emdin, C. A., Natarajan, P., Conrad, M. F. & Kathiresan, S. Genetic analysis of venous thromboembolism in UK Biobank identifies the ZFPM2 locus and implicates obesity as a causal risk factor. Circ. Cardiovasc. Genet. 10, e001643 (2017). · DOI
  25. Klarin, D. et al. Genome-wide association analysis of venous thromboembolism identifies new risk loci and genetic overlap with arterial vascular disease. Nat. Genet. 51, 1574–1579 (2019). · DOI · Paper page
  26. Dentali, F. et al. Non-O blood type is the commonest genetic risk factor for VTE: results from a meta-analysis of the literature. Semin. Thrombosis Hemost. 38, 535–548 (2012). · DOI
  27. Tang, N. et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J. Thrombosis Haemost. 18, 1094–1099 (2020). · DOI · Paper page
  28. Llitjos, J. et al. High incidence of venous thromboembolic events in anticoagulated severe COVID‐19 patients. J. Thrombosis Haemost. 18, 1743–1746 (2020). · DOI · Paper page
  29. Middeldorp, S. et al. Incidence of venous thromboembolism in hospitalized patients with COVID‐19. J. Thrombosis Haemost. 18, 1995–2002 (2020). · DOI · Paper page
  30. Lodigiani, C. et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thrombosis Res. 191, 9–14 (2020). · DOI · Paper page
  31. Levi, M., Thachil, J., Iba, T. & Levy, J. H. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 7, e438–e440 (2020). · DOI · Paper page
  32. Spiezia, L. et al. COVID-19-related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure. Thrombosis Haemost. 120, 998–1000 (2020). · DOI · Paper page
  33. Wichmann, D. et al. Autopsy findings and venous thromboembolism in patients with COVID-19. Ann. Intern. Med. 173, 268–277 (2020). · DOI · Paper page
  34. Khan, I. H., Savarimuthu, S., Leung, M. S. T. & Harky, A. The need to manage the risk of thromboembolism in COVID-19 patients. J. Vasc. Surg. 72, 799–804 (2020). · DOI
  35. Cheng, Y. et al. ABO blood group and susceptibility to severe acute respiratory syndrome. JAMA 293, 1447 (2005).
  36. Loscertales, M. et al. ABO blood group phenotypes and Plasmodium falciparum malaria: unlocking a pivotal mechanism. Adv. Parasitol. 65, 1–50 (2007). · DOI
  37. Boren, T., Falk, P., Roth, K., Larson, G. & Normark, S. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 262, 1892–1895 (1993). · DOI · Paper page
  38. Lindesmith, L. et al. Human susceptibility and resistance to Norwalk virus infection. Nat. Med. 9, 548–553 (2003). · DOI · Paper page
  39. Wang, D.-S. et al. ABO blood group, hepatitis B viral infection and risk of pancreatic cancer. Int. J. Cancer 131, 461–468 (2012). · DOI
  40. Foster, M. T. & Labrum, A. H. Relation of infection with Neisseria gonorrhoeae to ABO blood groups. J. Infect. Dis. 133, 329–330 (1976). · doi:10.1093/infdis/133.3.329
  41. Anstee, D. J. The relationship between blood groups and disease. Blood 115, 4635–4643 (2010). · DOI · Paper page
  42. Sandler, S. G., Chen, L. N. & Flegel, W. A. Serological weak D phenotypes: a review and guidance for interpreting the RhD blood type using the RHD genotype. Br. J. Haematol. 179, 10–19 (2017). · doi:10.1111/bjh.14757
  43. Flegr, J. Influence of latent Toxoplasma infection on human personality, physiology and morphology: pros and cons of the Toxoplasma-human model in studying the manipulation hypothesis. J. Exp. Biol. 216, 127–133 (2012). · DOI · Paper page
  44. Dardé, M. L., Ajzenberg, D. & Smith, J. Population structure and epidemiology of Toxoplasma gondii. In: Toxoplasma gondii the Model Apicomplexan: Perspectives and Methods, (eds Weiss, L. M. & Kim K.) (Academic Press, London, 2007). · doi:10.1016/b978-012369542-0/50005-2
  45. Xiao, A. T., Tong, Y. X. & Zhang, S. False negative of RT‐PCR and prolonged nucleic acid conversion in COVID‐19: Rather than recurrence. J. Med. Virol. 92, 1755–1756 (2020). · DOI · Paper page
  46. West, C. P., Montori, V. M. & Sampathkumar, P. COVID-19 testing. Mayo Clin. Proc. 95, 1127–1129 (2020). · DOI · Paper page
  47. Winichakoon, P. et al. Negative nasopharyngeal and oropharyngeal swabs do not rule out COVID-19. J. Clin. Microbiol. 58, e00297–20 (2020). · DOI · Paper page
  48. Garratty, G., Glynn, S. A. & McEntire, R., Retrovirus Epidemiology Donor Study. ABO and Rh(D) phenotype frequencies of different racial/ethnic groups in the United States. Transfusion 44, 703–706 (2004). · DOI · Paper page
  49. Austin, P. C. Absolute risk reductions and numbers needed to treat can be obtained from adjusted survival models for time-to-event outcomes. J. Clin. Epidemiol. 63, 46–55 (2010). · DOI
  50. Nishiura, H. et al. Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19). Int. J. Infect. Dis. 94, 154–155 (2020). · DOI · Paper page
  51. He, X. et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat. Med. 26, 672–675 (2020). · DOI · Paper page
  52. Yang, R., Gui, X. & Xiong, Y. Comparison of clinical characteristics of patients with asymptomatic vs symptomatic Coronavirus Disease 2019 in Wuhan, China. JAMA Netw. Open 3, e2010182 (2020). · DOI · Paper page
  53. Kim, G.-u et al. Clinical characteristics of asymptomatic and symptomatic patients with mild COVID-19. Clin. Microbiol. Infect. 26, 948.e1–948.e3 (2020). · DOI · Paper page
  54. Kucirka, L. M., Lauer, S. A., Laeyendecker, O., Boon, D. & Lessler, J. Variation in false-negative rate of reverse transcriptase polymerase chain reaction-based SARS-CoV-2 tests by time since exposure. Ann. Intern. Med. 173, 262–267 (2020). · DOI · Paper page
  55. Yip, S. Sequence variation at the human ABO locus. Ann. Hum. Genet. 66, 1–27 (2002). · DOI · Paper page
  56. Gray, R. J. A class of k-sample tests for comparing the cumulative incidence of a competing risk. Ann. Stat. 16, 1141–1154 (1988). · DOI · Paper page
  57. Himmelstein, D. S. et al. Open collaborative writing with Manubot. PLOS Comput. Biol. 15, e1007128 (2019). · DOI

Cited by

See all 581

Metadata

Authors
Zietz, M., Zucker, J., & Tatonetti, N. P.
Venue
Nature Communications
Published
2020-11-13
Volume
11
Issue
1
Pages
5761-5761
ISSN
2041-1723 (ISSN-L)
OpenAlex
W3105088458
Cited by
581
References
10
FWCI
69.94
Type
journal article
Language
en
Open access
gold
Licence
Funders
  • U.S. Department of Health & Human Services | NIH | U.S. National Library of Medicine (5 T15 LM007079-27)
  • U.S. Department of Health & Human Services | National Institutes of Health (1R35GM131905-01)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Associations between blood type and COVID-19 infection, intubation, and death. https://app.cochat.ai/papers/10.1038/s41467-020-19623-x
The paper
Zietz, M., Zucker, J., & Tatonetti, N. P. (2020). Associations between blood type and COVID-19 infection, intubation, and death. Nature Communications. https://doi.org/10.1038/s41467-020-19623-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.